BIONOMICS LIMITED - Announcements

0.00%

1.0¢

Currently unlisted.

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

BNO	New BNC105 Data Presented at AACR Conference	PRICE SENSITIVE	22/04/09	66.31KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	15/04/09	80.41KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/09	2.71MB	Share
BNO	Key Institutional Investor Supports BNO Capital Raising	PRICE SENSITIVE	10/02/09	30.19KB	Share
BNO	BNO - Open Briefing	PRICE SENSITIVE	05/02/09	51.61KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	17.35KB	Share
BNO	Open Briefing - CEO on Update	PRICE SENSITIVE	15/01/09	62.41KB	Share
BNO	BNC210 Successfully Completes Safety Studies	PRICE SENSITIVE	17/12/08	24.55KB	Share
BNO	Bionomics - Options Underwriting	PRICE SENSITIVE	16/12/08	28.12KB	Share

BNONew BNC105 Data Presented at AACR Conference
22/04/09	PRICE SENSITIVE	66.31KB	Share
BNOAppendix 4C - quarterly
15/04/09	PRICE SENSITIVE	80.41KB	Share
BNOHalf Yearly Report and Accounts
25/02/09	PRICE SENSITIVE	2.71MB	Share
BNOKey Institutional Investor Supports BNO Capital Raising
10/02/09	PRICE SENSITIVE	30.19KB	Share
BNOBNO - Open Briefing
05/02/09	PRICE SENSITIVE	51.61KB	Share
BNOAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	17.35KB	Share
BNOOpen Briefing - CEO on Update
15/01/09	PRICE SENSITIVE	62.41KB	Share
BNOBNC210 Successfully Completes Safety Studies
17/12/08	PRICE SENSITIVE	24.55KB	Share
BNOBionomics - Options Underwriting
16/12/08	PRICE SENSITIVE	28.12KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

BIONOMICS LIMITED - Announcements

Announcements

Top Stories